Brain Cancer | Tumor

CURE’s brain cancer page features the latest cancer news and updates on brain cancer Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in brain cancer.

Understanding Your Risk for Brain Metastases

January 26th 2021, 5:00am

Video

Katie’s Journey With Stage IV Ocular Melanoma That Has Spread to the Brain

January 20th 2021, 5:00am

Video

Ivy’s Journey With Stage IV Non–Small Cell Lung Cancer That Has Spread to the Brain

January 20th 2021, 5:00am

Video

Discussing the Potential for Brain Metastases With Patients

January 20th 2021, 5:00am

Video

Cancer Types Associated With Brain Metastases

January 20th 2021, 5:00am

Video

Study Shows No Further Improvement in Prognosis of Patients with Recurrent High-Grade Glioma

December 22nd 2020, 2:00pm

Article

Researchers try new drug combination to improve overall survival in patients with recurrent high-grade glioma, but are unsuccessful.

FDA Approves Investigational New Drug Application of Novel Therapy for Brain Cancer, Allowing the Treatment to Be Studied in Humans

December 21st 2020, 11:00pm

Article

The approval of an investigational new drug application will allow Berubicin’s manufacturer to begin studying the investigational drug in adults with glioblastoma who have previously failed their first treatment.

How Joe Biden’s Experience With Cancer Influenced My Journey

December 10th 2020, 5:30pm

Article

President-elect has a well known personal relationship with cancer as his son Beau Biden was diagnosed with glioblastoma and passed from this disease. This high-profile journey and story had an impact on my own journey with cancer.

NCI Research Project Identifies Genomic Mutations That Helped 'Exceptional Responders', 15-Year-Old Cancer Survivor Dies of COVID-19, and More

November 27th 2020, 4:00pm

Article

From the National Cancer Institute releasing promising research data into the genomic mutations that helped “exceptional responders” survive on treatment when others didn’t, to a 15-year-old Kentucky cancer survivor dying from COVID-19, here’s what’s happening in the cancer landscape this week.

FDA Accelerates Approval of Danyelza for Children and Adults with Relapsed or Refractory High-Risk Neuroblastoma

November 25th 2020, 11:13pm

Article

The Food and Drug Administration’s approval of Danyelza comes as a result of two trials that assessed the efficacy of the drug in patients with relapsed or refractory high-risk neuroblastoma in the bone or bone marrow who did not have sufficient response to prior therapies.